{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:51:24Z","timestamp":1773294684627,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/jcp.0b013e318267c304","type":"journal-article","created":{"date-parts":[[2012,8,25]],"date-time":"2012-08-25T06:44:07Z","timestamp":1345877047000},"page":"653-660","source":"Crossref","is-referenced-by-count":28,"title":["Does Atomoxetine Improve Executive Function, Inhibitory Control, and Hyperactivity?"],"prefix":"10.1097","volume":"32","author":[{"given":"Peter M.","family":"Wehmeier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Schacht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Ulberstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Schneider-Fresenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"Lehmkuhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf W.","family":"Dittmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Banaschewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(05)66915-2","article-title":"Attention-deficit hyperactivity disorder.","volume":"366","author":"Biederman","year":"2005","journal-title":"Lancet"},{"key":"R2-11-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpsycho.2005.03.011","article-title":". The neurophysiology of attention-deficithyperactivity disorder.","volume":"58","author":"di Michele","year":"2005","journal-title":"Int J Psychophysiol"},{"issue":"suppl 1","key":"R4-11-20210128","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00023210-200923000-00005","article-title":"Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.","volume":"23","author":"Arnsten","year":"2009","journal-title":"CNS Drugs"},{"issue":"suppl 8","key":"R5-11-20210128","first-page":"21","article-title":"Executive functions in attention-deficithyperactivity disorder.","volume":"67","author":"Doyle","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R6-11-20210128","first-page":"235","article-title":"Lowe P, et al..","volume":"17","author":"Riccio","year":"2002","journal-title":"The continuous performance test: a window on the neural substrates for attention Arch Clin Neuropsychol"},{"key":"R7-11-20210128","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1469-7610.2005.01469.x","article-title":". Assessing medication effects in the MTA study using neuropsychological outcomes.","volume":"47","author":"Epstein","year":"2006","journal-title":"J Child Psychol Psychiatry"},{"issue":"5","key":"R8-11-20210128","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1440-1754.1997.tb01625.x","article-title":"Discrimination of attention deficit hyperactivity disorder by the continuous performance test.","volume":"33","author":"Levy","year":"1997","journal-title":"J Paediatr Child Health"},{"key":"R9-11-20210128","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/cap.2008.0166","article-title":". Atomoxetine and neuropsychological function in children with attention-deficithyperactivity disorder: results of a pilot study.","volume":"19","author":"Maziade","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R10-11-20210128","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.1983.04390010091012","article-title":". A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls.","volume":"40","author":"Porrino","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"R11-11-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0166-4328(97)00165-4","article-title":"Clinical foundations of hyperactivity research.","volume":"94","author":"Taylor","year":"1998","journal-title":"Behav Brain Res"},{"key":"R14-11-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/108705470100500204","article-title":". Validation of the ADHD Rating Scale as a clinician administered and scored instrument.","volume":"5","author":"Faries","year":"2001","journal-title":"J Atten Disord"},{"key":"R15-11-20210128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/j.1552-4604.1985.tb02837.x","article-title":"Objectively measured hyperactivityI. Comparison with normal controls.","volume":"25","author":"Schechter","year":"1985","journal-title":"J Clin Pharmacol"},{"key":"R16-11-20210128","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00004583-199203000-00002","article-title":". Specificity of inattention, impulsivity and hyperactivity to the diagnosis of attention-deficit hyperactivity disorder.","volume":"31","author":"Halperin","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R17-11-20210128","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00004583-199603000-00015","article-title":". Objective measurement of hyperactivity and attentional problems in ADHD.","volume":"35","author":"Teicher","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatr"},{"key":"R18-11-20210128","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/74737","article-title":". Functional deficits in basal ganglia of children with attention-deficithyperactivity disorder shown with functional magnetic resonance imaging relaxometry.","volume":"6","author":"Teicher","year":"2000","journal-title":"Nat Med"},{"key":"R19-11-20210128","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/cap.2007.0090","article-title":"Utility of objective measures of activity and attention in the assessment of therapeutic response to stimulants in children with attention-deficithyperactivity disorder.","volume":"18","author":"Teicher","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R20-11-20210128","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00787-004-0365-3","article-title":". Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate.","volume":"13","author":"Heiser","year":"2004","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"R21-11-20210128","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00787-006-0571-2","article-title":". Is OPTAx useful for monitoring the effect of stimulants on hyperactivity and inattention A brief report.","volume":"16","author":"Tabori-Kraft","year":"2007","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"2","key":"R22-11-20210128","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/17405620801937764","article-title":"CPT performance, motor activity, and continuous relations to ADHD symptom domains: a developmental study.","volume":"7","author":"Brocki","year":"2010","journal-title":"Eur J Dev Psychol"},{"key":"R23-11-20210128","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1744-9081-6-32","article-title":". Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention.","volume":"6","author":"Oades","year":"2010","journal-title":"Behav Brain Funct"},{"key":"R24-11-20210128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF02244547","article-title":"A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants.","volume":"104","author":"Paulus","year":"1991","journal-title":"Psychopharmacology"},{"key":"R25-11-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/1469-7610.00304","article-title":"Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research.","volume":"39","author":"Tannock","year":"1998","journal-title":"J Child Psychol Psychiatry"},{"key":"R26-11-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/87565649609540637","article-title":"Research on executive function in a neurodevelopmental context: application of clinical measures.","volume":"12","author":"Denckla","year":"1996","journal-title":"Dev Neuropsychol"},{"key":"R27-11-20210128","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.biopsych.2004.12.005","article-title":". Varieties of attention-deficithyperactivity disorder-related intra-individual variability.","volume":"57","author":"Castellanos","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R28-11-20210128","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/geronj\/48.6.P263","article-title":"Attentional blocks are not responsible for age-related slowing.","volume":"48","author":"Salthouse","year":"1993","journal-title":"J Gerontol"},{"key":"R29-11-20210128","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF00909976","article-title":"The ecological validity of laboratory and analogue assessment methods of ADHD symptoms.","volume":"19","author":"Barkley","year":"1991","journal-title":"J Abnorm Child Psychol"},{"key":"R30-11-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/87565649109540488","article-title":". Subtype analysis of commission errors on the Continuous Performance Test.","volume":"7","author":"Halperin","year":"1991","journal-title":"Dev Neuropsychol"},{"key":"R31-11-20210128","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1176\/ajp.156.6.891","article-title":". Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI.","volume":"156","author":"Rubia","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R34-11-20210128","first-page":"839","article-title":"Clinical global impressions.","volume":"21","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"R35-11-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1753-2000-3-5","article-title":". Morning and evening behavior in children and adolescents treated with atomoxetine once daily for attention-deficithyperactivity disorder (ADHD): findings from two 24-week, open-label studies.","volume":"3","author":"Wehmeier","year":"2009","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"R36-11-20210128","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1198\/000313002533","article-title":"Corrgrams: exploratory displays for correlation matrices.","volume":"56","author":"Friendly","year":"2002","journal-title":"Am Stat"},{"key":"R37-11-20210128","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00213-007-0840-x","article-title":". Efficacy and safety of atomoxetine for attention-deficithyperactivity disorder in children and adolescentsmeta-analysis and meta-regression analysis.","volume":"194","author":"Cheng","year":"2007","journal-title":"Psychopharmacology"},{"key":"R38-11-20210128","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00787-008-0725-5","article-title":". Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficithyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naive Swedish children and adolescents.","volume":"18","author":"Svanborg","year":"2009","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"R39-11-20210128","first-page":"678","article-title":"Using meta-analysis to compare the efficacy of medications for attention-deficithyperactivity disorder in youths.","volume":"34","author":"Faraone","year":"2009","journal-title":"P T"},{"key":"R40-11-20210128","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/CHI.0b013e3181bc730d","article-title":". Characteristics of placebo responders in pediatric clinical trials of attention-deficithyperactivity disorder.","volume":"48","author":"Newcorn","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R41-11-20210128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"R42-11-20210128","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/cap.2010.0142","article-title":". Neuropsychological outcomes across the day in children with ADHD treated with atomoxetine. Results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion tracking device.","volume":"21","author":"Wehmeier","year":"2011","journal-title":"J Child Adolesc Psychopharmacology"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e318267c304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:00:13Z","timestamp":1620957613000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201210000-00011"}},"subtitle":["Results From a Placebo-Controlled Trial Using Quantitative Measurement Technology"],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318267c304","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}